• The Company
    • Company Overview

    • Technology Overview

    • Leadership
      • Robert Freedman, CEO

      • Cheul H. Cho, CSO

      • Christian T. Darabant, COO

      • Leslie Z. Benet

      • James S. MacDonald

      • Martin L. Yarmush

    • Investor Relations

  • Products & Services
    • HµREL® microlivers

    • Products

    • Contract Services

    • HµRELToxTM

    • HµRELviralTM

    • HµRELfluxTM

    • HµRELZooPlateTM

    • ACEA/HµREL®
      continuous monitoring

  • Publications
    • Scientific papers

    • Videos

    • Webinars

    • Industry collaborations

  • News & Events
    • News & Press Releases

    • Coming Events

    • Webinars

  • Customer Service

HµRELToxTM
multi-readout, repeat-dose
DILI screening
DILI screening

Hurel microlivers afford better prediction than 3D

Toxicology Research
HµRELviralTM
Long-enduring infectious liver disease platform
Time-Based
Toxicity Ratios*
A new marker for hepatotoxic chronicity

TAAP
*patent pending
HµRELfluxTM
a new, patent-pending
efflux transport
assay method
DMPK
Superior intrinsic clearance
and biotransformation of
low-turnover drugs

DMD

News
Coming Events
  • Life Sciences executive Christian Darabant to lead Hurel’s expansion

    see press release

  • May 2019
    Hurel announces partnership with Cyprotex. Read the announcement here. View the data sheet here.
Entire News Chronology
  • RTP DMDG - December 3, 2019
    The Raleigh-Durham Airport Hilton Doubletree - 4810 Page Creek Lane, Durham, North Carolina, 27703
    Topic: “Toxicological and Pharmacological ADME Challenges While Growing-Up”
    Learn more: http://www.rtpdmdg.org/events
  • Delaware Valley DMDG - January 21, 2020
Entire List of Coming Events
divide
bottomtag
linkedin  facebook  twitter
divide
The Company  Technology  Products & Services  Publications  News & Events  Contact  Site Map
Copyright © 2013 Hµrel® Corporation